|
Dora S.V., Khalimov Yu.Sh., Mekhtiev S.N., Lisker A.V., Zimina M.V., Semikova G.V., Volkova A.R., Cherebillo I.V., Polyakova Yu.V.
Correlation between estrogen deficiency and non-alcoholic fatty liver disease in female patients
|
№8 / 2024
|
|
Karoli N.A.
Achievement of control in patients with bronchial asthma and obesity: Possibilities of bariatric surgery
|
№6 / 2024
|
|
Tanashyan M.M., Antonova K.V., Spryshkov N.E., Panina A.A.
Metabolic markers of cerebrovascular pathology
|
№5 / 2024
|
|
Zhuchkova S.M., Busalaeva E.I., Markova T.N., Semenova V.A.
Obesity in medical students: What has changed in 18 years
|
№3 / 2024
|
|
Budnevsky A.V., Tribuntseva L.V., Chernik T.A., Ivanchuk Yu.S., Kravchenko A.Ya.
Impact of osteoarthritis on the asthma clinical course: Focus on physical activity and quality of life
|
№2 / 2024
|
|
Larina V.N., Ryzhikh A.A.
Healthy lifestyle devotion index as a possible indicator of more severe course of novel coronavirus infection and long-term recovery
|
№9 / 2023
|
|
Tribuntceva L.V., Avdeev S.N., Budnevsky A.V., Choporov O.N., Prozorova G.G., Olysheva I.A.
Assessment of physical activity level in patients with asthma depending on body weight
|
№9 / 2023
|
|
Evgenieva A.V., Noskov S.M., Zhomova M.V., Lavrukhina A.A.
Influence of obesity at frailty syndrome manifestations in persons over 75 years old
|
№9 / 2023
|
|
Skuridina D.V., Demidova T.Yu.
Clinical and metabolic peculiarities in male patients with type 2 diabetes mellitus and hypogonadism
|
№9 / 2023
|
|
Usanova A.A., Lavrenova E.A., Kunyaeva T.A., Kuzma F., Novikova E.K., Sergutova N.P., Chatkina T.A.
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors
|
№8 / 2023
|
|
Shestakova E.A., Lazareva A.A., Mazurina N.V., Komshilova K.A., Ershova E.V.
Telemedical technologies in the treatment of obesity as a way of interdisciplinary approach implementation
|
№7 / 2023
|
|
Kislyak O.A., Mikaelyan A.A., Starodubova A.V., Kosyura S.D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
|
№3 / 2023
|
Русский
